Tech Company Financing Transactions

Kira Pharmaceuticals Funding Round

RA Capital, Vivo Capital and A Plus Finance invested in a $53.5 million Series B funding round for Kira Pharmaceuticals. The round was recorded on 1/8/2021.

Transaction Overview

Announced On
1/8/2021
Transaction Type
Venture Equity
Amount
$53,500,000
Round
Series B
Investors

RA Capital (Lead Investor) (Matthew Hammond)

Vivo Capital (Lead Investor) (Dandan Dong)

A Plus Finance

Foresite Capital

Qiming Ventures

Quan Capital

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Cambridge, MA 02114
USA
Phone
Undisclosed
Email Address
Overview
Kira Pharmaceuticals is a biotechnology company developing complement-targeted therapies to treat immune-mediated diseases. Enabled by its LOGIC drug discovery platform, the company is committed to advancing first-in-class and best-in-class therapies to transform the lives of patients with complement-driven diseases.
Profile
Kira Pharmaceuticals LinkedIn Company Profile
Social Media
Kira Pharmaceuticals Company Twitter Account
Company News
Kira Pharmaceuticals News
Facebook
Kira Pharmaceuticals on Facebook
YouTube
Kira Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Frederick Beddingfield
  Frederick Beddingfield LinkedIn Profile  Frederick Beddingfield Twitter Account  Frederick Beddingfield News  Frederick Beddingfield on Facebook
Chief Medical Officer
Richard Lee
  Richard Lee LinkedIn Profile  Richard Lee Twitter Account  Richard Lee News  Richard Lee on Facebook
Co-Founder
Gonghua Pan
  Gonghua Pan LinkedIn Profile  Gonghua Pan Twitter Account  Gonghua Pan News  Gonghua Pan on Facebook
VP - Bus. Development
Kathy He
  Kathy He LinkedIn Profile  Kathy He Twitter Account  Kathy He News  Kathy He on Facebook
VP - Bus. Development
Dana Zhang
  Dana Zhang LinkedIn Profile  Dana Zhang Twitter Account  Dana Zhang News  Dana Zhang on Facebook
VP - R & D
Wenru Song
  Wenru Song LinkedIn Profile  Wenru Song Twitter Account  Wenru Song News  Wenru Song on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/8/2021: Scorpion Therapeutics venture capital transaction
Next: 1/8/2021: Ablacon venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary